inno.N Page.
Employees: 51-200
Founded date: 1986
Investors 1
| Date | Name | Website |
| - | Stic Inves... | stic.co.kr |
Mentions in press and media 7
| Date | Title | Description |
| 27.10.2025 | Kolmar Korea Selected for Government-Led 'AI Factory' Initiative -- Driving Innovation in K-Beauty Manufacturing | The only cosmetics company chosen by the Ministry of Trade, Industry and Resources for the "AI Factory" project Enables agile, small-batch, multi-product production to meet diverse client needs in real time SEOUL, South Korea, Oct... |
| 07.05.2024 | Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea | HANGZHOU, China and SEOUL, South Korea, May 7, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean ... |
| 07.05.2024 | Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea | HANGZHOU, China and SEOUL, South Korea, May 7, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean ... |
| 09.02.2022 | HK inno.N Corporation announces an Equity Buyback for KRW 24,200 million worth of its shares. | HK inno.N Corporation (KOSDAQ:A195940) announces a share repurchase program. Under the program, the company will repurchase up to KRW 24,200 million worth of its shares according to the contract with Korea Investment & Securities Co., L... |
| 20.12.2021 | Prellis Biologics 3D bioprints lymph node to unlock antibody discovery at pace | Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform. Effectively a functioning immune system in a dish, the firm’s platform i... |
| 17.12.2021 | Inventia Life Science raises $25M, launches ‘RASTRUM’ 3D bioprinting technology in the U.S. | Australian 3D bioprinting specialist Inventia Life Science has announced the closure of a Series B funding round that has seen it raise $25 million (USD). Led by Blackbird Ventures and supported by long-term backer Skip Capital, the investm... |
| 01.12.2021 | Introducing the 3D printable blood plasma bio-ink that accelerates the wound-healing process | Scientists at the Irish RCSI University of Medicine and Health Sciences have developed a novel bio-ink that can be 3D printed into tissues capable of fast-forwarding the human wound-healing process. By integrating the platelet-rich plasma (... |